Cargando…

Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis

BACKGROUND: Clopidogrel monotherapy is guideline-recommended in symptomatic peripheral artery disease (PAD). The advent of new antithrombotic strategies prompts an updated analysis of available evidence on antiplatelet therapy for PAD. METHODS: We searched MEDLINE, Embase and CENTRAL through January...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Carlo, Marco, Di Minno, Giovanni, Sayre, Tobias, Fazeli, Mir Sohail, Siliman, Gaye, Cimminiello, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573731/ https://www.ncbi.nlm.nih.gov/pubmed/32819249 http://dx.doi.org/10.2174/1570161118666200820141131

Ejemplares similares

A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies
por: Montoya, Jose G., et al.
Publicado: (2021)

The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
por: Polo Friz, Hernan, et al.
Publicado: (2015)

PB1935: CARDIOTOXICITY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITORS: A REVIEW OF REAL-WORLD OBSERVATIONAL EVIDENCE
por: Balijepalli, Chakrapani, et al.
Publicado: (2023)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Overcoming limitations of current antiplatelet drugs: A concerted effort for more profitable strategies of intervention
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2011)

Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease
por: Di Minno, Giovanni, et al.
Publicado: (2014)

Comparative Effectiveness Review of Antiplatelet Agents in Peripheral Artery Disease
por: Schmit, Kristine, et al.
Publicado: (2014)

Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus)
por: Sanna, Guido, et al.
Publicado: (2011)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and Safety
por: de Bruijn, Annefleur M., et al.
Publicado: (2018)

Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs
por: Tufano, A., et al.
Publicado: (2011)

Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study
por: Cimminiello, Claudio, et al.
Publicado: (2010)

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease
por: Tsai, Thomas T., et al.
Publicado: (2015)

Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries
por: Kronlage, Mariya, et al.
Publicado: (2017)

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
por: Katsanos, Konstantinos, et al.
Publicado: (2015)

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
por: Balijepalli, Chakrapani, et al.
Publicado: (2017)

Efficacy and safety of a single intra-articular injection of 6 ml Hylan G-F 20 compared to placebo in Chinese patients with symptomatic knee osteoarthritis: C-SOUND study, a 26-week multicenter double-blind randomized placebo-controlled trial in China
por: Ke, Yan, et al.
Publicado: (2021)

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study
por: Kremers, B. M. M., et al.
Publicado: (2023)

Efficacy and safety of antiplatelet-combination therapy after drug-eluting stent implantation
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Long-Term Safety and Efficacy of Antiplatelet Therapy in Patients With Cerebral Infarction With Thrombocytopenia
por: Guo, Shijie, et al.
Publicado: (2021)

Meta-Analysis Addressing the Efficacy and Safety of Antiplatelet Agents in Patients With COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease
por: Biswas, Minakshi P., et al.
Publicado: (2021)

Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting
por: Bai, Chaobo, et al.
Publicado: (2022)

Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis
por: Choi, Jay Chol, et al.
Publicado: (2016)

Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease
por: Nicolajsen, Chalotte W., et al.
Publicado: (2023)

Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
por: Li, Xiao‐Qiu, et al.
Publicado: (2022)

Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis
por: Ma, Gaoting, et al.
Publicado: (2021)

Safety and efficacy of stenting for symptomatic intracranial artery stenosis: a systematic reveiw and meta-analysis
por: Shi, Ting, et al.
Publicado: (2023)

Safety and efficacy of endovascular recanalization for symptomatic non-acute atherosclerotic intracranial large artery occlusion
por: Chu, Xi, et al.
Publicado: (2023)

Peripheral interventions and antiplatelet therapy: Role in current practice
por: Singh, Pahul, et al.
Publicado: (2017)

Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials
por: Tang, Tao, et al.
Publicado: (2021)

Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
por: Hemstra, Line Ea, et al.
Publicado: (2018)

Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease
por: Adam, Luise, et al.
Publicado: (2023)

Clinical impact of the infrapatellar location in symptomatic peripheral arterial disease patients
por: Chiabrando, Juan G., et al.
Publicado: (2023)

Relationships of drinking and smoking with peripheral arterial stiffness in Chinese community-dwelling population without symptomatic peripheral arterial disease
por: Fu, Shihui, et al.
Publicado: (2017)

Precision antiplatelet therapy
por: Rocca, Bianca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_35mm93t625k8gpunmg3km2m4nv